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Abstract
This study reports the use of gold nanoparticle-based surface-enhanced Raman scattering (SERS) for probing the
differentiation of mouse embryonic stem (mES) cells, including undifferentiated single cells, embryoid bodies (EBs), and
terminally differentiated cardiomyocytes. Gold nanoparticles (GNPs) were successfully delivered into all 3 mES cell
differentiation stages without affecting cell viability or proliferation. Transmission electron microscopy (TEM) confirmed the
localization of GNPs inside the following cell organelles: mitochondria, secondary lysosome, and endoplasmic reticulum.
Using bright- and dark-field imaging, the bright scattering of GNPs and nanoaggregates in all 3 ES cell differentiation stages
could be visualized. EB (an early differentiation stage) and terminally differentiated cardiomyocytes both showed SERS
peaks specific to metabolic activity in the mitochondria and to protein translation (amide I, amide II, and amide III peaks).
These peaks have been rarely identified in undifferentiated single ES cells. Spatiotemporal changes observed in the SERS
spectra from terminally differentiated cardiomyocyte tissues revealed local and dynamic molecular interactions as well as
transformations during ES cell differentiation.
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Introduction
Embryonic stem (ES) cells are pluripotent cells that have the
capability to self-renew and differentiate into multiple tissue types.
These cells hold great promise in the repair of damaged adult
tissues by stem cell therapy, tissue engineering, and regenerative
medicine [1–4]. In vitro differentiation of mouse ES (mES) cells is
normally initiated by an aggregation step that leads to the
formation of cell aggregates, termed EBs, which upon suitable
stimulation differentiate into a wide range of specialized cell types
such as neuronal cells [5], cardiac muscle cells [3,6], and blood
cells [7]. Identification of markers specific to each differentiation
stage is essential for tracking the differentiation of ES cells.
Techniques such as immunocytochemistry, fluorescence micros-
copy, polymerase chain reaction, and RNA in situ hybridization
are generally used to measure the expression of stage-specific
embryonic antigen-1, and POU family transcription factors Oct-
4/Oct-3 [8], and CD9 [9] for undifferentiated state of ES cells.
However, these techniques have certain limitations: they involve
lengthy procedures lasting hours or days; require a large number
of cells, labels, or markers; and cannot be carried out on living cells
as they involve lysis, fixation, or both. Therefore, in this rapidly
expanding field, the need for faster noninvasive methods to
characterize and monitor the differentiation of ES cells in situ and
in real-time is more evident than ever before.
Raman spectroscopy is a laser-based optical technique used for
the analysis of molecular bonds in a sample. One advantage of
Raman spectroscopy is that exogenous labeling is not required in this
technique. A Raman spectrum serves as a ‘‘molecular fingerprint’’ of
a sample, yielding information on molecular bonds, conformations,
and intermolecular interactions. The approach is non-invasive and is
therefore ideally suited for the study of live cells. In spite of its
advantages, its practical uses have been significantly limited because
the Raman scattering signal is intrinsically weaker than most other
fluorescence signals. Various methods of enhancement have been
developed to extend the detection limit of this method. Among these,
enhancement with noble metal nanostructures, a technique termed
surface-enhanced Raman scattering (SERS), was found to be
particularly interesting. Using this method, it was possible to probe
single molecules adsorbed onto a single silver nanoparticle [10,11].
The sensitivity of SERS has been shown to be as high as 10
14–10
15,
which is comparable to that of the fluorescence detection method
[10,12]. This facilitates the application of SERS to the detection of
biomolecules such as DNA [13], DNA/RNA mononucleotides [14],
and proteins [15]. SERS has been successfully used for labeling cells
[16] and tissues [17], for multiplexed biomarker labeling to monitor
apoptotic processes [18], and for real-time monitoring of single live
cell signaling processes [19]. The most recent generation of SERS
tags [20] can be used for the targeted detection of biomarkers such as
cancer antigens found in the blood or on the cell surface. This
involves the use of immunoassay approaches for in vitro cancer
diagnosis [21,22], in vivo cancer targeting and imaging [23], and
mapping local pH in live cells [24] as well as in subcellular organelles
in live cells [25].
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nanoparticles (such as silver or gold) are normally loaded into cells
by different methods such as general incubation (fluid-phase
uptake) or ultrasonication-assisted uptake [26–29]. Gold nanopar-
ticles (GNPs) efficiently scatter visible light and do not blink or
photobleach. Their optical properties are controlled by their
plasmons, which are collective oscillations of their conduction
electrons. Due to their chemical inactivity, GNPs are generally
regarded to be more suitable for incorporation into living cells
[26,30,31].
ES cell differentiation involves many biochemical and biophys-
ical cellular changes. When cells begin to differentiate toward a
specific phenotype, they produce specific proteins that assist their
functions. The unique ability of ES cells to differentiate toward
any phenotype indicates that there are significant biochemical
differences between undifferentiated ES cells and differentiated
cells. In this study, we used SERS in conjunction with GNPs to
detect biochemical changes in mES cells during in vitro
differentiation. To the best of our knowledge, there are no reports
on the use of SERS to study ES cells and identify the changes that
occur during differentiation.
Thus, SERS in conjunction with GNPs was used to detect
biochemical differences across 3 differentiation stages, i.e.,
undifferentiated single ES cells, embryoid bodies (EBs), and
differentiated cardiomyocytes. Cells in all 3 differentiation states
were treated with GNPs by fluid-phase uptake, and nanoparticle
localization inside the cytoplasm and cell organelles was studied
and confirmed by transmission electron microscopy (TEM)
analysis. GNP cytotoxicity on cell viability and proliferation was
estimated by the neutral red uptake (NRU) assay, which is based
on the uptake of the supravital dye neutral red (NR) by viable cells
and MTT assay based on the mitochondrial dehydrogenase
activity of metabolically active cells. The SERS fingerprints from
each differentiation stage were used to distinguish the stages
involved in the differentiation of undifferentiated single ES cells to
terminally differentiated cardiac muscle cells via the EB state.
Additionally, the spatiotemporal measurements of SERS finger-
prints provided insight into the dynamics of molecular interactions
and transformations that occur at different locations with time in
differentiated cardiomyocytes.
Materials and Methods
ES cell culture, EB formation, and EB differentiation into
cardiomyocytes
The mES cell line B6G-2 that expresses the green fluorescent
protein (GFP) ubiquitously was purchased from RIKEN BRC
(Tsukuba, Japan) [32]. ES cells were routinely cultured and
expanded on mitotically inactivated STO cells (ECACC) [33] as a
feeder layer (75 000 cells/cm
2) in 100-mm Petri dishes (Iwaki,
Japan) coated with 0.1% (w/v) gelatin (Sigma). They were
maintained at 60–70% confluence to preserve an undifferentiated
phenotype in humidified 5% CO2 at 37uC with daily medium
exchange for 2 days. The cells were collected by trypsin-EDTA
treatment (0.05% v/v trypsin and 0.53 mM EDTA; Invitrogen)
for 2–3 min in 5% CO2 at 37uC. After centrifugation at 1000 rpm
for 5 min, single ES cell suspensions were obtained, which were
used either for subculturing or for differentiation studies. B6G2
cells express GFP ubiquitously under the b-actin promoter, and
the characteristic green fluorescence from GFP helps in distin-
guishing ES cells from STO feeder cells.
After 2 days of mES cell culture on feeder cells, the cells were
trypsinized (0.05% trypsin-EDTA) to prepare single cell suspen-
sions, and the cell number was determined. The single cell
suspension was used for EB formation by the hanging drop
method [6]. EBs were formed on the inner side of the lid of a 90-
mm Petri dish (Iwaki, Japan) in hanging drops that contained 800
cells in 20 ml of DMEM medium without leukemia inhibiting
factor (LIF). The dishes contained 15–20 ml of sterilized Milli-Q
water to prevent evaporation from the droplets. After incubation
for 3 days at 37uCi n5 %C O 2, the EBs were collected and used for
differentiation studies.
To induce the differentiation of EBs into cardiomyocytes, the
EBs were transferred onto 0.1% (w/v) gelatin-coated 8-well glass
chamber slides (Iwaki, Japan). Each well contained 2 EBs in 0.4 ml
of LIF-free medium. After incubation for 12 days under the above
conditions with daily medium exchange, spontaneous beatings
were observed in the tissues derived from EBs.
The other cell cultivation conditions used were as follows. STO
cells were inactivated by exposure to 10 mg/ml mitomycin C
(Wako, Japan). The ES cell culture medium consisted of
Dulbecco’s modified Eagles medium (DMEM, high glucose
4.5 g/l) (Nacalai Tesque, Kyoto, Japan) supplemented with 15%
(v/v) ES-cell qualified heat-inactivated fetal bovine serum
(Invitrogen, USA), 2 mM L-glutamine (Invitrogen), 0.1 mM
nonessential amino acids (Invitrogen), 50 U/ml penicillin,
50 mg/ml streptomycin (Invitrogen), and 0.1 mM b-mercaptoeth-
anol (Invitrogen) in the presence of 1000 U/ml recombinant
murine LIF (mLIF; Millipore, USA). mLIF addition inhibits the
spontaneous differentiation of mES cells into major embryonic
tissues.
Loading of GNPs into single ES cells, EBs, and
cardiomyocytes
Gold colloid suspensions in water (particle size of 40 nm,
60 nm, and 100 nm) were purchased from BBinternational Ltd.
(UK). Figure 1A is a schematic illustration of the experimental
setup used to load colloidal GNPs into pluripotent undifferentiated
single ES cells, EBs, and cardiomyocytes. In the case of single ES
cells, GNPs were introduced into the cells by a fluid-phase uptake
method in which cells (1610
6/ml) were suspended in ES cell
culture medium without LIF at the desired concentration (10%
colloidal solution, v/v) and incubated for 2–4 h in 5% CO2 at
37uC. Ten- to twenty-microliter aliquots from each treatment
were placed onto a cover glass embedded slide glass (Sekisui
Kenkyo Plate, Japan) for microscopic observations and SERS
measurements.
In the case of EBs, 40–50 EBs (200–250 mm in diameter) were
taken in a 12-mm glass-bottom tissue culture dish (Iwaki, Japan)
containing 800 ml ES cell culture medium without LIF. The GNP
solution (10% colloidal solution, v/v) was added, and the dish was
incubated for 2–4 h in 5% CO2 at 37uC. The EB suspension was
placed on a microscopic slide where 0.3-mm silicone polymer
frames served as chambers. These samples were overlaid with
cover glasses and used to visualize GNPs in EBs and also to
conduct SERS measurements.
In the case of cardiomyocytes, 12-d grown EB-derived
cardiomyocytes in 8-well chamber slides were treated with a
defined concentration (10% colloidal solution, v/v) of 100 nm
GNPs and incubated for 2–4 h in 5% CO2 at 37uC. The chamber
frame was dismantled, and a clean cover glass (0.15 mm) was
placed over the chamber slide to visualize the GNPs in the tissue
and to conduct SERS measurements in cardiomyocyte tissues.
Prior to the SERS measurements, all samples were washed 2–3
times with PBS to remove the culture media and GNPs present
outside the cells. Optical microscopy images of the prepared
samples are shown in Figures 1B–D.
ES Cell Differentiation by SERS
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proliferation
To assess the toxicity of the gold colloids on mES cell viability,
cells were treated with the desired concentration of gold colloids in
water. Cell viability and proliferation were measured in a 96-well
plate using the CellTiter 96 Aqueous One solution cell
proliferation assay (Promega, USA), according to the manufac-
turer’s instructions. In this assay, metabolically active cells reduce
an MTS tetrazolium compound into colored and medium-soluble
formazan via NADPH or NADH produced by mitochondrial
dehydrogenase enzymes [34]. The formazan concentration is
directly proportional to the number of viable cells and is estimated
from the absorbance at 490 nm using a 96-well microplate reader
(SH-1000, Corona Electronics, Ibaraki, Japan).
Figure 1. Schematic illustration showing the experimental setups and steps involved in the loading of colloidal GNP suspensions
into mES cells at 3 differentiation stages, i.e., undifferentiated single cells, EBs (cell aggregates), and terminally differentiated
cardiomyocytes (A). Representative optical microscopic images of undifferentiated mES cells (B), cardiomyocyte tissue (C), and EBs (D) after GNP
loading.
doi:10.1371/journal.pone.0022802.g001
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5,
1.8610
5, and 2.4610
5/ml) in DMEM culture medium were
treated with 10% (v/v) GNP suspensions (40, 60, and 100 nm) in
different vials and incubated for 1 h in 5% CO2 at 37uC. One
hundred microliters of the sample mixture containing 12 000,
18 000, or 24 000 cells and nanoparticles was transferred to each
well of a 96-well plate and incubated for another 2 h and 24 h. At
the end of the incubation period, 20 ml of MTS reagent (Promega,
USA) was added to each well, and formazan formation by
metabolically active cells was measured every hour for 4 h by
continuing the incubation under the above conditions. Another set
of experiments were performed to determine the dose-dependent
toxicity of GNPs. Different concentrations (0, 5, 10, 15, and 20%)
of GNPs (40 and 100 nm) were loaded into wells containing
24 000 ES cells. After 72 h of incubation, MTS reagent (20 ml)
was added to each well. The formazan absorbance was estimated
for 4 h, and the result corresponds to the ES cell proliferation in
the presence of GNPs. Cells without nanoparticles served as
controls, while medium and medium with nanoparticles served as
blanks in the experiment. The absorbance derived from the
experimental samples was subtracted from the respective blanks to
obtain the net absorbance for each treatment. All the experiments
were performed in triplicates and repeated twice.
NRU assay for determining GNP cytotoxicity effects on ES
cells
The NRU cytotoxicity assay is a cell survival/viability assay
based on the ability of viable cells to incorporate and bind NR,
which is a weak cationic supravital dye that readily penetrates cell
membranes by nonionic diffusion and predominately accumulates
intracellularly in lysosomes [35]. Alterations of the cell surface or
the sensitive lysosomal membrane lead to lysosomal fragility and
other changes that gradually become irreversible. Such changes
produced by toxic substances or nanoparticles can lead to
decreased NR uptake and binding, thereby allowing the
spectrophotometric differentiation of viable, damaged, or dead
cells. Cytotoxicity is expressed as the concentration-dependent
reduction in NR uptake after chemical exposure, thus providing a
sensitive integrated signal of both cell integrity and growth
inhibition.
ES cells at different cell densities (0.6610
5, 0.9610
5, and
1.2610
5 cells/ml in DMEM culture medium) were treated with
GNPs of various sizes (40, 60, and 100 nm) to a final concentration
of 10% (v/v) colloids, which were prepared in separate vials. Next,
200 ml each of sample mixture containing 12 000, 18 000, or
24 000 cells and nanoparticles was transferred to each well of a 96-
well plate and incubated for 24 h at 5% CO2 and 37uC. At the
end of the incubation period, the medium was aseptically aspirated
from the wells, and 100 ml of NR working solution (40 mg/ml,
1:100 NR stock solution with culture medium) was added to each
well. The plate was left for incubation under the above conditions
for 2 h. The NR stock solution (4 mg/ml) was prepared by
dissolving 40 mg of NR in 10 ml of PBS. The NR staining solution
was removed from each well by aspiration. The cells were then
washed with 150 ml of PBS, and the fluid was removed by
aspiration. This was followed by the addition of 150 mlo fN R
destaining solution (50% ethanol, 49% deionized water, and 1%
glacial acetic acid, equivalent to 10 ml water, 10 ml ethanol, and
0.2 ml glacial acetic acid), and the plate was rapidly shaken on a
microtiter plate shaker for 10 min or until the NR dye had been
extracted from the cells and had formed a homogeneous solution.
The absorbance of the NR extract was measured at 540 nm in a
microtiter plate reader spectrophotometer (SH-1000, Corona
Electronics, Ibaraki, Japan) using blanks that contained no cells
as references. All the experiments were performed in triplicates
and repeated twice.
TEM analysis
GNP uptake was examined by TEM to confirm that the GNPs
had actually entered the cells and were not just attached to the cell
surface. For TEM imaging, cardiomyocyte tissue samples treated
with GNPs were fixed in 2.5% (v/v) glutaraldehyde (TAAB
Laboratories, UK) dissolved in 0.1 M sodium phosphate buffer
(pH 7.0) (Wako, Japan), and the samples were incubated for
30 min at room temperature. The samples were then washed 3
times with 0.1 M phosphate buffer containing 8% sucrose,
followed by post fixation for 45 min at room temperature with
2% (w/v) osmium tetroxide (EM grade) in sucrose-phosphate
buffer. This was followed by washing with sucrose-phosphate
buffer and sequential complete dehydration of the specimen in a
series of increasing ethanol concentrations (60 to 100%). The
samples were then infiltrated and embedded in epoxy resin.
Ultrathin sections (80 nm), which were taken parallel to the
bottom of the culture dish, were placed on TEM copper grids and
poststained with 2% aqueous uranyl acetate for 20 min, followed
by staining with lead citrate for 4 min at room temperature [36].
The grids were examined, and TEM images were acquired with
iTEM (SIS, Germany) software at an accelerating voltage of
80 kV using a Jeol 1200EX transmission electron microscope (Jeol
Ltd., Japan) equipped with a Morada digital CCD camera system
(Olympus SIS, Germany).
Experimental setup for imaging and SERS measurements
The experimental setup employed for measuring SERS signals
from all 3 ES cell differentiation stages, i.e., single cells, EBs, and
cardiomyocytes, is shown in Figure 2. From each stage, samples
loaded with GNPs were placed onto microwell glass plates (Sekisui
Kenkyo Plate, Japan). The samples were then positioned on the
sample stage of a Zeiss inverted optical microscope (Axiovert 200).
White light from a tungsten-halogen lamp illuminated the samples
through a condenser lens, and dark and bright-field images were
taken with a digital camera (Olympus, SP-510UZ). The Raman
excitation source was a 632.8 nm He-Ne laser beam (Melles Griot,
05-LHP-151) that was focused on the sample through an oil
immersion objective lens (6100 magnification). The size of the
laser focus was approximately 1 mm in diameter in the focal plane,
and the power of the laser beam through the objective lens was
130 mW. Raman scattering light from the sample was introduced
into a spectrometer consisting of a polychromator (Acton
Research, Spectra Pro 300i) and a CCD camera (Roper Scientific,
PI-MAX1024HG18). A notch filter (Semlock, NF01-488/532/
635) placed in the optical path of the signal light cut the excitation
laser beam. Raman signals were collected in the spectral interval of
400–2000 cm
21.
Results and Discussion
Ultramicroscopic imaging of GNP accumulation
Nanoparticle entry and localization inside ES cells, EBs, and
cardiomyocyte tissues were confirmed by TEM. The detailed
TEM procedure is described in the supporting information. The
results of the TEM observations are presented in Figures 3A–C.
The TEM images showed that GNPs were taken up by ES cells
and were localized in the cytoplasm and certain cell organelles,
mostly in the form of aggregates. It should be noted that
aggregated nanoparticles ordinarily have high SERS activity
[37]. GNPs were localized in the perinuclear region and in cell
organelles such as the mitochondria, secondary lysosomes, and
ES Cell Differentiation by SERS
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C). It is very interesting to note that GNPs, independent of size,
accumulated in the mitochondria, which is regarded as the cell’s
‘‘machinery of life.’’ GNPs were internalized in the mitochondria
and did not cause apoptosis or necrosis of the cells (Figures 3A–
C). The mitochondrial cristae were clearly visible in the electron
micrographs of the cells (Figures 3A, B). The TEM images
revealed that most GNPs were embedded in the ES cells in the
form of aggregates. Induction of GNP aggregation by the culture
medium was also verified by incubating the same concentration of
GNPs in the ES cell culture medium for the same time and then
examining the samples by dynamic light scattering. The results
showed that the particle size increase was less than 30%. The
formation of large aggregates was not observed in the TEM
images. This suggests that the localization and aggregation of
GNPs occurs after GNP uptake by cells. Nanoparticles that had
accumulated in different cell organelles appeared as aggregates;
this phenomenon has also been reported by Kneipp et al. [26]. For
the GNP uptake measurements, 80–100 cells were analyzed for
GNP of each size. In the majority of the cells, GNPs were found to
be localized in the mitochondria (data not shown). In addition,
GNP aggregates were found in the secondary lysosome and other
cell organelles. Generally, it is difficult to direct nanomaterials to a
specific cell organelle such as the nucleus or mitochondria, and
directed entries are commonly mediated by specific signal peptide
sequences [38–43]. In the present study, we found that clustered
GNPs were present in the mitochondria of ES cells without such
surface modifications. This could be a very useful feature in future
studies. It is clear from the TEM images that GNP treatment did
not result in any cytotoxic effects on the cells, such as apoptosis or
necrosis. We further confirmed GNP accumulation inside the cells
by using energy-dispersive X-ray spectroscopy (EDX) with the
Horiba EMAX-7000 system (Figure S1).
GNP cytotoxicity on ES cell viability and proliferation
The TEM imaging results suggested that ES cells loaded with
GNPs were healthy and had normal ultrastructural features that
were similar to those of control cells that did not contain
nanoparticles. We further studied GNP cytotoxicity by exposing
ES cells to GNPs over a period of time and then measuring ES cell
viability and proliferation by the MTS and NRU assays. The cell
viability and proliferation were unaffected both in short-term (2 h)
and long-term (24 h) incubations at all the cell densities tested and
with GNPs of all 3 sizes (Figures 3D, E). Instead, ES cell growth
and proliferation increased in the presence of GNPs. The increase
was greater at all cell densities that contained 100 nm GNPs in
comparison to controls without GNPs and cells with 40 and 60 nm
GNPs subjected to short-term (2 h) and long-term (24 h) exposure
(Figures 3D, E). On the other hand, the results from cells
exposed to different concentrations (5, 10, 15, and 20%, v/v) of
GNPs (40 and 100 nm) for 72 h showed that in comparison to
control cells, i.e., cells without any GNPs, cell growth and
proliferation were unaffected at all the GNP concentrations tested.
These results suggested that higher GNP concentrations (20%) did
not affect ES cell proliferation even after longer exposure times
(Figure 3F). The GNP cytotoxicity effects on ES cells were
confirmed by using the NR uptake assay, which tests the ability of
viable cells to incorporate the NR dye into lysosomes. Both cell
viability and proliferation were uninhibited after 24 h incubation
at all cell densities tested and with GNPs of all 3 sizes (Figure 3G);
instead, the presence of GNPs tended to increase ES cell growth
and subsequent proliferation. This increase was prominent at
higher cell densities treated with 40 and 60 nm GNPs
(Figure 3G). Microscopic observations also confirmed that
GNP-loaded cells showed higher growth. This was evidenced
from the fact that the number of NR dye uptake cells was higher in
these wells than in control wells that did not contain GNPs (not
Figure 2. Illustration of the experimental setup employed for SERS spectra measurements. He-Ne laser excitation (632.8 nm) was
delivered to a sample placed on an inverted microscope, and this sample was used for SERS spectral measurements from single ES cells, EBs, and
cardiomyocyte tissue samples. The SERS spectra were acquired by detection of scattering signals sent through a pinhole and delivered into the
polychromator and CCD camera.
doi:10.1371/journal.pone.0022802.g002
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PLoS ONE | www.plosone.org 5 August 2011 | Volume 6 | Issue 8 | e22802Figure 3. TEM imaging and GNP cytotoxic effects on ES cell viability and proliferation. TEM images showing GNP localization in ES cells,
EBs, and cardiomyocyte organelles (A–C). It was observed that 40-nm GNPs accumulated in the mitochondria, secondary lysosome, and other
cytoplasmic organelles (A), 60-nm particles localized in the mitochondria and secondary lysosome (B), and 100-nm particles accumulated in the
mitochondria and endoplasmic reticulum in the cytoplasm (C). G, M, L, N, and C indicate GNP, mitochondria, secondary lysosome, nucleus, and
cytoplasm, respectively. ER indicates the endoplasmic reticulum, and small dark spheres represent ribosomes attached to the ER. TEM images
captured at a voltage of 80 kV with a Jeol 1200EX electron microscope. Cytotoxic effects of GNPs (40, 60, and 100 nm) on ES cell viability for 2 h (D)
and on cell proliferation for 24 h (E). The effect of the GNP concentration on ES cell proliferation for 72 h (F) at varying ES cell densities. The
ES Cell Differentiation by SERS
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which were based on the reduction of the MTS tetrazolium
compound by the mitochondrial dehydrogenase enzymes of
metabolically active cells. We also confirmed the cytotoxic effects
of GNPs by using Cayman’s lactate dehydrogenase (LDH)
cytotoxicity assay kit. In this assay, cell death is measured in
response to chemical compounds or environmental factors
through a 2-step reaction. Moreover, the assay measures the
membrane integrity, which is an indicator of the effect of GNPs on
cell viability and proliferation. The results showed that in
comparison to control cells, the presence of GNPs in cells
protected them from regular damage or lysis. This was
demonstrated by the lower release of LDH from cell membranes
into the culture medium, leading to a decrease in the reduction of
tetrazolium salt (INT) to highly colored formazan that absorbs at
490 nm (data not shown). The results from these 3 assays
confirmed that the GNPs tested (40, 60, and 100 nm) supported
the growth and proliferation of mES cells. Previous reports on the
cytotoxic effects of GNPs on human leukemia (K562) cells
suggested that although GNPs were not acutely toxic, a gold-salt
(AuCl4) precursor solution showed greater than 90% toxicity at
200 mM [30]. In the present study, the presence of GNPs
stimulated ES cell growth and proliferation, suggesting that the
free radicals formed during cellular growth were probably
quenched by GNPs (Figures 3D, E, G). In fact, it is well-known
that free radical formation during cellular growth hinders cell
proliferation [44] and that GNPs act as antioxidants to overcome
such problems [31,45–47]. A recent study in which a human
prostate cancer cell line (PC-3) was treated with 30–90 nm GNPs
concluded that no toxic effect could be attributed to the ability of
GNPs to reduce the amount of potentially harmful reactive oxygen
species (ROS) in cells [48]. It has been reported that small GNPs
(0.8–15 nm) showed significant size-dependent toxicity in fibro-
blasts, epithelial cells, and melanoma cells [49]. However, in the
present study, no cytotoxic effects were observed on cell growth
and cell proliferation (Figure 3F). In comparison to GNP,
fluorescent polymer nanoparticles reduced the viability of mES
cells by 40% [50]. These results suggest that ES cell viability and
proliferation were not inhibited by the GNPs present. Instead,
GNPs appeared to inhibit ROS generation, resulting in increased
viability and proliferation of ES cells.
Imaging of ES cells, EBs, and cardiomyocytes with GNPs
followed by SERS measurements
For the SERS measurements, single ES cells, EBs, and
cardiomyocyte tissues loaded with GNPs were observed under
an optical microscope using a 6100 objective lens. Microscopic
images of representative samples are shown in Figures 4 A–C.
The images in Figures 4B and 4C are unclear because EBs and
cardiomyocytes are too large and bulky for microscopic imaging
with a high magnification lens. Only some parts of the EB and
cardiomyocyte are in focus, and overlap of the defocused region
degrades the image quality. We could confirm a difference in
nanoparticle aggregation in single ES cells in comparison to EBs
and terminally differentiated cardiomyocyte tissues. The GNPs in
EBs and cardiomyocytes were self-assembled into submicron-sized
aggregates that could be observed by bright-field imaging
(Figures 4B and 4C). Since GNPs and nanoaggregates in single
ES cells are too small to be observed by bright-field imaging, dark-
field imaging was employed to detect these, as shown in
Figure 4A. The incubation time and culture medium were the
same in all nanoparticle uptake studies; therefore, the difference in
the size of aggregates formed could be attributed to differences in
the cell function state in EBs and cardiomyocytes.
SERS measurements were performed by focusing a He-Ne laser
beam onto these GNPs. The position of the laser focus was
adjusted on a GNP or GNP nanoaggregate by moving the sample
stage. Adjustment of the laser focus was confirmed by backscat-
tering of the light of the He-Ne laser beam due to strong Rayleigh
scattering by GNPs, as shown in Figure 4B (red spot in a white
circle). Representative SERS spectra measured from undifferen-
tiated single cells, EBs, and cardiomyocytes loaded with 100 nm
GNPs are shown in Figures 4D–F. Apart from specific
differences in the Raman peaks (discussed below), the spectra
from the EBs and cardiomyocyte tissue samples showed noticeable
differences from that of single ES cells. First, more SERS peaks
were collected for the EBs and cardiomyocyte tissue samples.
Second, the SERS spectra acquired from the EBs and cardiomy-
ocytes showed background at the base level, unlike the spectra
from single ES cells, which may be due to the overlap of multiple
Raman peaks (Figures 4D–F).
Using the same laser excitation, we could not collect any
Raman spectral data from a control cell without GNPs. Only spots
with GNPs yielded an SERS spectrum. However, half of the
measured GNPs did not yield an SERS spectrum. This is expected
because the SERS spectrum arises from molecules that are
adsorbed at a specific site of GNPs where the electromagnetic field
is enhanced. In addition, the enhancement factor of the
electromagnetic field is strongly dependent on the nanoparticle
shape and aggregate structure [11,26]. Thus, there is low
probability that SERS-active GNP is spontaneously formed in
the cell. However, we succeeded in measuring clear Raman peaks
from ,10% of these nanoparticles.
As reported earlier by some groups, the SERS spectra from gold
or silver nanoparticles in biological cells consist of many
complicated vibration bands, and the spectral profile differs from
particle to particle. This spectral variation is caused by the
presence of various macromolecules in the cells, such as proteins,
lipids, nucleic acids, and carbohydrates. In many cases, the
assignment of Raman peaks to specific vibrational modes of a
biomolecule is considerably difficult. This is a common issue in
Raman analysis of biological cells. Therefore, our band assign-
ment, which is summarized in Table 1 and discussed below, is
tentative and is based on data reported in literature [51–63].
SERS profiles from undifferentiated single ES cells
In Figure 4D, the Raman peak at 642 cm
21 originated from
the C-C twist of tyrosine, and the peak at 932 cm
21 corresponded
to the proline ring v(C-C) vibration mode [51–53]. The strong
peak at 1141 cm
21 corresponded to the ribose phosphate of
nucleotides, and peaks 1281, 1321, and 1343 cm
21 were assigned
to the cytosine, guanine, and adenine bases, respectively [53,54]. A
very strong peak at 1534 cm
21 was ascribed to lipid stretches in
single ES cells [51].
SERS profiles from EBs
The SERS spectra derived from EBs and terminally differen-
tiated cardiomyocytes showed many peaks, unlike the spectra from
experiments were performed in a 96-well plate using the MTS assay. Figure 3D and 3E show the values at the end of 3 h of incubation with the
MTS reagent, while Figure 3F shows the results after 4 h of incubation. The cytotoxic effects of GNPs on ES cell viability and proliferation after 24 h
(G) at varying cell densities. The experiments were performed in a 96-well plate using the NRU assay.
doi:10.1371/journal.pone.0022802.g003
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PLoS ONE | www.plosone.org 7 August 2011 | Volume 6 | Issue 8 | e22802Figure 4. SERS spectra characteristic of the 3 differentiation stages of mES cells. The dark-field microscopic image of undifferentiated
single ES cells loaded with 100 nm GNPs (A), and the corresponding SERS spectrum from the particle encircled inside the ES cell (D). The bright-field
microscopic image of EBs treated with 100 nm GNPs and gold nanoaggregates visible in the dark (B). The corresponding SERS spectrum measured
from the encircled area of EB (E). The bright-field microscopic image of 12-d-grown cardiomyocyte tissues loaded with 100 nm GNPs appeared as
aggregates in the circled area (C) and in the corresponding SERS spectrum (F). Images captured by a digital camera (Canon, Japan) after excitation
with a He-Ne laser (632.8 nm) at a power of 130 mW using a 6100 objective lens. SERS spectra of both ES cells and EBs acquired with 30-s laser
acquisitions. The SERS spectrum of the cardiomyocyte tissue samples was acquired with 1-s acquisitions.
doi:10.1371/journal.pone.0022802.g004
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the peak at 663 cm
21 was assigned to thymine and guanine bases.
The very strong peak at 1223 cm
21 was characteristic of protein
amide III (O-sheet) [57] while that at 1310 cm
21 originated from
the adenine ring as well as the cT (CH2-CH3) twisting of proteins
[53]. The strong peak at ,1400 cm
21 was assigned to the COO-
symmetric stretching of amino acids [58], and the weak peaks at
1565 cm
21 and 1580 cm
21 were ascribed to amide II, guanine
and adenine bases, respectively. The peak at 1596 cm
21
originated from the ring mode of adenine or guanine. The peak
at 1604 cm
21 was believed to originate from the mitochondria,
based on an earlier Raman microspectroscopic study by the
Hamaguchi group using isolated mitochondria from yeast [59].
SERS profiles from cardiomyocytes
The SERS profiles from 12-d grown beating cardiomyocyte
tissues loaded with 100 nm GNPs were measured using 1-s laser
exposures. In the case of ES cells and EBs, 30-s exposures were
used. In Figure 4F, the peak at 645 cm
21 was assigned to the C-
C twist of tyrosine, and the peak at 787 cm
21 corresponded to the
O-P-O stretch band of DNA and RNA [52]. In addition, the peaks
at 900 and 949 cm
21 were ascribed to the C-C skeletal stretch in
Table 1. Tentative assignment of SERS peaks derived from undifferentiated ES cells, EBs, and differentiated cardiomyocyte tissues
[51–63].
ES cell (cm
21) Peak assignment
Embryoid body
(cm
21) Peak assignment
Cardiomyocyte
tissue (cm
21) Peak assignment
642 C-C twist tyrosine
O-P-O stretch in DNA
663 T,G (DNA bases)
C: ring breathing
645 C-C twist tyrosine
C-N stretch in lipid/adenine
787 O-P-O stretch in RNA
Histidine
793 C-DNA: phosphodiester stretching
v(C-C), a-helix
737 O-P-O stretch in DNA
O-P-O stretch in RNA
813 Proline ring v(C-C)
PO2
2 str (protein)
869 Phenylalanine ring vibration
DNA backbone: C-O stretch
787 C-O-C skeletal mode;
disaccharide
C-C skeletal stretch in protein
918 Ribose phosphate Histidine phosphate 813 P:C-C skeletal mode (random)
932 P: Amide III (O-sheet)
P: Amide III
940
1000–1003
Ribose phosphate
P: Amide III(O-sheet) 886
Phenylalanine
PO2
2
1060 C: base (cytosine)
G (guanine), CH def 1020
P: Amide III
C: base (cytosine)
Ribose phosphate
C-C stretching in protein
1141–1146 A: base
Proteins: CH3 deformation
A: ring Proteins: cT (CH2-CH3)
A: base
900 Nucleotides: base & Try, Phe
P: Amide III (O-sheet)
1220 Alanine, Try, G: base
dCH2
1090–1096 Proteins: CH3 deformation
Proteins: COO- symmetric stretching 949
P: Amide III
C: base (cytosine)
1270–1289 A, G, T
P: Amide II
C=C (lipid);
1138–1141
1223
A, G, T
P: Amide II
C=C (lipid); 1006
Proteins: cT (CH2-CH3)
A: base
Proteins: CH3 deformation
1321 A, C, G
1275–1283
A, C, G
Mitochondria
1071
1144
Alanine, Try, G: base
Proteins: COO- symmetric
stretching
1335 A, G, T
1165 P: Amide II
1310 C=C (lipid);
1353–1367 1190–1196 A, C, G
Mitochondria
1444 1337 P: Amide I
1484 1223
1534–1567
1394–1415 1256–1275
1316–1318
1481–1502
1520–1565 1329–1340
1596–1604 1361
1404–1407
1484–1502
1531–1567
1596–1604
1647
doi:10.1371/journal.pone.0022802.t001
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respectively [51]. The very strong peak at 1006 cm
21 originated
from the phenylalanine ring vibration mode [51–55]. The medium
peak at 1190 cm
21 was assigned to nucleotide bases as well as to
tryptophan and phenylalanine. The medium peaks at
,1223 cm
21 were assigned to amide III (O-sheet) [57,26]. The
strong peak at ,1400 cm
21 was assigned to the COO- symmetric
stretching of amino acids [58,61], and 2 other very strong peaks at
Figure 5. Spatiotemporal measurements of the SERS spectra derived from 100-nm GNP aggregates in 12-d-grown cardiomyocyte
tissue in glass-bottom chamber dishes (A). The SERS spectra (B–D) from different GNP aggregates. The spectra were acquired at an exposure of
1 s employing He-Ne (632.8 nm) laser excitations at a power of 130 mW, as shown by the arrows in Figure 5A.
doi:10.1371/journal.pone.0022802.g005
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21 were assigned to the adenine or guanine and
adenine or thymine bases, respectively. The very strong peak at
1604 cm
21 was regarded as the mitochondrial signature. In
addition, the peak at 1647 cm
21 was assigned to amide I [19,53].
Spatiotemporal SERS measurements from cardiomyocyte
tissues
Figure 5A shows the micrograph of cardiomyocyte tissue. This
is the same as the sample shown in Figure 4C, and the SERS
spectra collected from 3 different locations are shown in
Figures 5B–D. The SERS spectra, although from the same
cardiomyocyte tissue, showed a different peak pattern, which
reflects the intracellular biomolecular distribution profile at these
locations. The spectral fingerprints further underwent drastic
changes for every 1-s exposure, suggesting that temporal changes
occur in the chemical nanoenvironment of the GNPs inside the
cardiomyocyte. Apart from the changes that occur in the spectral
signatures, increases in the SERS signal strength were also noted.
Occasionally, a few new peaks appeared besides to the red shift
observed in few peaks are also shown in Figures 5B–D, which
could be attributed to intracellular biomolecular dynamics and
transformations. The Raman peaks shown in these spectra are also
summarized in Table 1. Briefly, Raman peaks related to amino
acids and proteins were predominant in the spectral profile. We
also performed time-dependent scans for undifferentiated single
ES cells containing 40 nm nanoparticles (Figure S2), and EBs
containing 60 nm GNP (Figure S3) represented more of nucleic
acids and bases related peaks in undifferentiated ES cells. We also
confirmed the expression of the cardiomyocyte protein a-actinin in
12-d beating cardiomyocyte tissues by carrying out immunostain-
ing experiments (Figure S4).
Identification of Raman peaks related to differentiation
As mentioned above, many of the SERS peaks had overlapping
biochemical contributions, which is a common problem in
complex biological environments such as those found inside cells.
However, the purpose of this study was to identify specific Raman
peaks that could serve as probes for ES cell differentiation.
Therefore, we adopted a realistic approach by focusing on this
aspect of the study and considering cellular molecular function
during differentiation. SERS peaks derived from undifferentiated
single cells were mostly attributed to nucleic acids (DNA and
RNA), as shown in Figure 4D and Figure S2. This is due to the
high proliferation rate of undifferentiated ES cells and is in
agreement with reports from mouse and human ES cells based on
Raman microspectroscopy [54,56]. On the other hand, it is
noteworthy that the Raman peak at 1604 cm
21 that originated
from the mitochondria was specifically observed in EBs and
cardiomyocytes. This is strongly supported by the ultramicro-
graph data (Figures 3A–C) and reflects the high metabolic
activity of EBs and cardiomyocytes. In comparison to undiffer-
entiated single ES cells (Figure 4A and Figure S2), many
Raman peaks related to proteins, such as amide I, amide II,
amide III, COO
2 symmetric stretching, and CH3 deformation,
were observed in the region 1200–1700 cm
21 in EBs and
cardiomyocytes (Figures 4B, 4C, and 5; Figure S3). This
suggested that cell activity was at its maximum and driving the
cell toward its cellular fate. Therefore, terminally differentiated
cardiomyocytes carried out protein translation, post translation,
and cell signaling activities unlike undifferentiated single ES cells
during differentiation. In addition, SERS analysis clearly
demonstrated that EBs are not simple aggregates of ES cells
but are an early stage of embryonic differentiation in which
protein translation occurs at almost the same level as in
differentiated cardiomyocytes. Furthermore, we quantitatively
calculated 3 major molecular signatures—those of DNA/RNA,
protein translation activities (amide I, amide II, and amide III),
and mitochondria. These represent the high metabolic activities
of cells during the 3 stages of ES cell differentiation, i.e.,
undifferentiated single cells, EBs, and differentiated cardiomyo-
cytes (shown in Figure 6). As expected, undifferentiated single-
cell derived SERS spectra exhibited abundant DNA-RNA-
related peaks (O-P-O stretch DNA: 787 cm
21 and O-P-O
stretch RNA: 813 cm
21). Moreover, EBs and terminally
differentiated cardiomyocytes showed SERS spectra predomi-
nantly from proteins (amide I, amide II, and amide III) and
mitochondria (1604 cm
21); these are expressed as percentage
values.
Thus, we demonstrated that the SERS-based analysis of ES cells
has great potential in identifying Raman spectral features specific
to each stage of differentiation. Conventional Raman scattering
analysis of biological cells yields ensemble-averaged information of
numerous different molecules. In contrast, SERS arises from a
limited number of molecules adsorbed onto metal nanoparticles
and captures detailed molecular information that is buried in
ensemble-averaged conventional Raman spectra. This study
demonstrated that GNP uptake did not inhibit cell viability but
instead supported the proliferation of mouse ES cells. GNP
internalization was mostly localized to the mitochondria in all 3
differentiation stages of mES cells and was assumed to be cell-
specific. The results indicated that this method could be used to
deliver drugs or probes to mitochondria without compromising the
cell viability for in situ and real-time imaging and monitoring of
mitochondrial molecular dynamics. GNP administration further
enabled fast and noninvasive SERS-based molecular profiling of
ES cell differentiation. The results proved the advantages of this
method over other biochemical methodologies currently in use for
the quick profiling of mES cells without the use of any labels in
small numbers or even at the single cell level. Further extension of
the SERS-based method used in this study to induced pluripotent
stem (iPS) cells would probably reveal the molecular and
biochemical differences that exist between ES and iPS cells. Such
studies could also contribute to our understanding of the
reprogramming of somatic cells to iPS cells or specialized cells.
Figure 6. Quantitative SERS profiling of DNA/RNA, protein
translation activities (amide I, amide II, amide III), and
mitochondrial metabolic activities in single ES cells, EBs, and
cardiomyocytes. Calculations are expressed as percentage values.
Thirty samples were used to measure the DNA/RNA and protein
translation activities, and 20 samples were taken to determine the
mitochondrial activities from each stage of ES cell differentiation.
doi:10.1371/journal.pone.0022802.g006
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Figure S1 Energy dispersive X-ray (EDX) spectrum analysis of
GNPs accumulated cardiomyocyte tissues by 200 kV EMAX7000
(Horiba, Japan) coupled with HRTEM (Hitachi, H-8000). Peaks
at 2.12 and 9.71 keV energy levels unique to gold element, while
‘‘Cu’’ peak comes from copper grid that employed for TEM
specimen and ‘‘U’’ peak stands for uranyl acetate staining of tissue
specimen for better visualization of intracellular organizations.
(TIF)
Figure S2 Time-dependent measurement of SERS spectra from
single ES cell treated with 40 nm GNPs. Each spectrum acquired
with 30 s He-Ne laser exposures. Spectra were measured from the
particle indicated in the circle.
(TIF)
Figure S3 Time-dependent measurement of SERS spectra from
single EB treated with 60 nm GNPs. Each spectrum acquired with
30 s He-Ne laser exposures. Spectra were measured from the
aggregate indicated in the circle.
(TIF)
Figure S4 Immunostaining of beating cardiomyocyte tissue
derived from 12-d grown EB loaded with gold nanoparticles
(100 nm) expressing a-actinin, myofibriallar protein specific to
cardiomyocytes. GFP (A), TRITC-labeled a-actinin (B) DAPI (C),
and overlap (D). Scale bar 100 mm. In brief, 12-d grown
cardiomyocyte tissues were fixed with 4% (v/v) paraformaldehyde
for 20 min at RT followed by treatment with 2% (v/v) Triton X-
100 and blocking was achieved by 3% (w/v) BSA dissolved in PBS
buffer for 1–2 h at RT and incubated the specimens with a cardiac
specific primary antibody a-actinin (500 times dilutions) overnight
at 4uC. Specimens were washed with 0.05% Tween-20 in PBS and
then tissue specimens were incubated with TRITC-labeled
secondary antibody (SC 2092, 200 times dilution) for 3 h at RT.
DAPI was used for staining the nucleus followed by PBS washings
and specimens were mounted in 2–3 drops mounting solution and
examined microscopically.
(TIF)
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